Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
V

VIMAB Group AB (publ)
STO:VIMAB

Watchlist Manager
VIMAB Group AB (publ)
STO:VIMAB
Watchlist
Price: 2.58 SEK 2.79% Market Closed
Market Cap: kr122.7m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+20%
5Y
-
10Y
-
Liabilities
+
3Y
+88%
5Y
-
10Y
-
Equity
+
3Y
-
5Y
-
10Y
-

Balance Sheet Decomposition
VIMAB Group AB (publ)

Balance Sheet
VIMAB Group AB (publ)

Rotate your device to view
Balance Sheet
Currency: SEK
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
10
2
6
20
6
6
15
5
24
118
13
30
12
Cash
0
0
0
0
0
0
0
0
0
0
13
30
12
Cash Equivalents
10
2
6
20
6
6
15
5
24
118
0
0
0
Total Receivables
18
25
17
24
24
34
37
40
25
1
47
65
36
Accounts Receivables
17
25
16
24
24
33
37
35
24
0
40
54
24
Other Receivables
2
0
1
0
0
0
0
5
1
1
7
11
12
Inventory
0
0
0
0
0
0
0
0
0
0
28
42
54
Other Current Assets
12
15
13
13
13
22
24
22
7
0
3
32
15
Total Current Assets
40
42
36
57
44
62
76
66
56
119
91
168
118
PP&E Net
2
1
1
1
1
2
4
39
5
0
43
63
57
PP&E Gross
0
0
0
0
0
0
4
39
5
0
43
0
0
Accumulated Depreciation
0
0
0
0
0
0
9
30
3
0
65
0
0
Intangible Assets
1
1
0
0
0
5
4
8
3
0
13
22
30
Goodwill
84
90
92
92
92
111
102
102
67
0
2
85
59
Note Receivable
0
0
0
0
0
0
0
1
1
0
0
0
0
Long-Term Investments
0
0
0
0
0
1
1
0
0
0
47
0
0
Other Long-Term Assets
1
7
5
2
2
2
1
2
1
4
0
0
0
Other Assets
84
90
92
92
92
111
102
102
67
0
2
85
59
Total Assets
126
N/A
140
+11%
134
-4%
152
+13%
139
-9%
184
+32%
187
+2%
217
+16%
132
-39%
123
-7%
196
+60%
339
+73%
264
-22%
Liabilities
Accounts Payable
7
6
7
6
7
11
11
15
14
2
16
25
51
Accrued Liabilities
11
13
13
16
13
19
29
20
15
2
16
42
27
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
24
1
Current Portion of Long-Term Debt
1
4
0
2
2
11
6
28
2
0
3
26
39
Other Current Liabilities
11
13
8
18
13
25
26
21
20
2
64
33
62
Total Current Liabilities
30
36
28
42
35
66
72
84
51
6
100
150
181
Long-Term Debt
7
1
4
2
0
3
1
26
3
0
33
40
31
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
1
1
Minority Interest
0
0
0
0
0
1
1
1
0
0
0
8
0
Other Liabilities
0
14
0
0
0
10
0
0
0
0
7
61
33
Total Liabilities
38
N/A
50
+34%
32
-35%
44
+36%
35
-22%
79
+129%
74
-6%
111
+49%
54
-51%
6
-89%
139
+2 346%
260
+87%
246
-5%
Equity
Common Stock
0
0
0
1
1
1
1
1
1
1
4
4
5
Retained Earnings
23
17
27
34
29
24
33
26
3
40
138
143
221
Additional Paid In Capital
67
73
73
73
73
77
77
77
77
77
191
217
234
Other Equity
2
0
2
1
2
3
3
3
3
0
0
0
0
Total Equity
89
N/A
90
+1%
102
+13%
108
+6%
105
-3%
104
0%
113
+8%
106
-6%
78
-27%
117
+51%
57
-51%
79
+38%
18
-77%
Total Liabilities & Equity
126
N/A
140
+11%
134
-4%
152
+13%
139
-9%
184
+32%
187
+2%
217
+16%
132
-39%
123
-7%
196
+60%
339
+73%
264
-22%
Shares Outstanding
Common Shares Outstanding
34
40
40
3
3
3
3
3
3
3
19
22
24

See Also

Summary
VIMAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIMAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIMAB stock valuation using valuation multiples.
Wall Street Estimates
VIMAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIMAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.